CIK: 1787370 - Address: C/O Vir Biotechnology, Inc., 1800 Owens Street, Suite 900, San Francisco, CA 94158
10 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

2/26/24 19:31
2/22/24
VIRVir Biotechnology, Inc.DEHealthBioPrdBiological Products, (No DiagPang PhillipCAOEVP,ChieS-14610.050-15-6250D
2/16/24 18:56
2/16/24
VIRVir Biotechnology, Inc.DEHealthBioPrdBiological Products, (No DiagPang PhillipCAOEVP,ChieS-3410.240-3-1265D
1/3/24 14:47
1/2/24
VIRVir Biotechnology, Inc.DEHealthBioPrdBiological Products, (No DiagPang PhillipCAOEVP,ChieM.d1101.3808043268D
6/8/23 16:30
6/7/23
VIRVir Biotechnology, Inc.DEHealthBioPrdBiological Products, (No DiagPang PhillipCAOChief MeM.d81.53053188D
6/8/23 16:30
6/7/23
VIRVir Biotechnology, Inc.DEHealthBioPrdBiological Products, (No DiagPang PhillipCAOChief MeS.d-13025.950-5-3188D
2/24/23 20:29
2/23/23
VIRVir Biotechnology, Inc.DEHealthBioPrdBiological Products, (No DiagPang PhillipCAOChief MeS.d-7525.970-3-1198D
2/21/23 19:24
2/17/23
VIRVir Biotechnology, Inc.DEHealthBioPrdBiological Products, (No DiagPang PhillipCAOChief MeS-7125.290-3-2141D
1/25/23 20:01
1/24/23
VIRVir Biotechnology, Inc.DEHealthBioPrdBiological Products, (No DiagPang PhillipCAOChief MeS.d-90030.000-30-17144D
7/21/22 16:10
7/20/22
VIRVir Biotechnology, Inc.DEHealthBioPrdBiological Products, (No DiagPang PhillipCAOChief MeS.d-15030.000-5-3144D
6/22/22 17:40
6/21/22
VIRVir Biotechnology, Inc.DEHealthBioPrdBiological Products, (No DiagPang PhillipCAOChief MeS-12424.890-5-3144D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact